The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gandotinib Market Research Report 2025
Synopsis
Gandotinib is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
The global Gandotinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gandotinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gandotinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gandotinib include BioVision, Selleck Chemicals, BOC Sciences, TargetMol, MyBiosource, Adooq Bioscience, Toronto Research Chemicals, AbMole and Taiclone, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gandotinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gandotinib.
Report Scope
The Gandotinib market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gandotinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gandotinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioVision
Selleck Chemicals
BOC Sciences
TargetMol
MyBiosource
Adooq Bioscience
Toronto Research Chemicals
AbMole
Taiclone
Axon Medchem
CSNpharm
AA BLOCKS
MedKoo
Wuhan Sun-Shine Bio-Technology
Biosynth Carbosynth
Biorbyt
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
Production by Region
North America
Europe
China
Japan
Taiwan,China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gandotinib manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gandotinib by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gandotinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Gandotinib is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
The global Gandotinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gandotinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gandotinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gandotinib include BioVision, Selleck Chemicals, BOC Sciences, TargetMol, MyBiosource, Adooq Bioscience, Toronto Research Chemicals, AbMole and Taiclone, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gandotinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gandotinib.
Report Scope
The Gandotinib market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gandotinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gandotinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioVision
Selleck Chemicals
BOC Sciences
TargetMol
MyBiosource
Adooq Bioscience
Toronto Research Chemicals
AbMole
Taiclone
Axon Medchem
CSNpharm
AA BLOCKS
MedKoo
Wuhan Sun-Shine Bio-Technology
Biosynth Carbosynth
Biorbyt
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
Production by Region
North America
Europe
China
Japan
Taiwan,China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gandotinib manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gandotinib by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gandotinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Gandotinib Market Overview
1.1 Product Definition
1.2 Gandotinib Segment by Type
1.2.1 Global Gandotinib Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Gandotinib Segment by Application
1.3.1 Global Gandotinib Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Research
1.3.3 Medical
1.4 Global Market Growth Prospects
1.4.1 Global Gandotinib Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Gandotinib Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Gandotinib Production Estimates and Forecasts (2019-2030)
1.4.4 Global Gandotinib Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Gandotinib Production Market Share by Manufacturers (2019-2024)
2.2 Global Gandotinib Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Gandotinib, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Gandotinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Gandotinib Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Gandotinib, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Gandotinib, Product Offered and Application
2.8 Global Key Manufacturers of Gandotinib, Date of Enter into This Industry
2.9 Gandotinib Market Competitive Situation and Trends
2.9.1 Gandotinib Market Concentration Rate
2.9.2 Global 5 and 10 Largest Gandotinib Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Gandotinib Production by Region
3.1 Global Gandotinib Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Gandotinib Production Value by Region (2019-2030)
3.2.1 Global Gandotinib Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Gandotinib by Region (2025-2030)
3.3 Global Gandotinib Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Gandotinib Production by Region (2019-2030)
3.4.1 Global Gandotinib Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Gandotinib by Region (2025-2030)
3.5 Global Gandotinib Market Price Analysis by Region (2019-2024)
3.6 Global Gandotinib Production and Value, Year-over-Year Growth
3.6.1 North America Gandotinib Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Gandotinib Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Gandotinib Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Gandotinib Production Value Estimates and Forecasts (2019-2030)
3.6.5 Taiwan,China Gandotinib Production Value Estimates and Forecasts (2019-2030)
4 Gandotinib Consumption by Region
4.1 Global Gandotinib Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Gandotinib Consumption by Region (2019-2030)
4.2.1 Global Gandotinib Consumption by Region (2019-2024)
4.2.2 Global Gandotinib Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Gandotinib Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Gandotinib Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Gandotinib Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Gandotinib Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Gandotinib Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Gandotinib Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Gandotinib Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Gandotinib Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Gandotinib Production by Type (2019-2030)
5.1.1 Global Gandotinib Production by Type (2019-2024)
5.1.2 Global Gandotinib Production by Type (2025-2030)
5.1.3 Global Gandotinib Production Market Share by Type (2019-2030)
5.2 Global Gandotinib Production Value by Type (2019-2030)
5.2.1 Global Gandotinib Production Value by Type (2019-2024)
5.2.2 Global Gandotinib Production Value by Type (2025-2030)
5.2.3 Global Gandotinib Production Value Market Share by Type (2019-2030)
5.3 Global Gandotinib Price by Type (2019-2030)
6 Segment by Application
6.1 Global Gandotinib Production by Application (2019-2030)
6.1.1 Global Gandotinib Production by Application (2019-2024)
6.1.2 Global Gandotinib Production by Application (2025-2030)
6.1.3 Global Gandotinib Production Market Share by Application (2019-2030)
6.2 Global Gandotinib Production Value by Application (2019-2030)
6.2.1 Global Gandotinib Production Value by Application (2019-2024)
6.2.2 Global Gandotinib Production Value by Application (2025-2030)
6.2.3 Global Gandotinib Production Value Market Share by Application (2019-2030)
6.3 Global Gandotinib Price by Application (2019-2030)
7 Key Companies Profiled
7.1 BioVision
7.1.1 BioVision Gandotinib Corporation Information
7.1.2 BioVision Gandotinib Product Portfolio
7.1.3 BioVision Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.1.4 BioVision Main Business and Markets Served
7.1.5 BioVision Recent Developments/Updates
7.2 Selleck Chemicals
7.2.1 Selleck Chemicals Gandotinib Corporation Information
7.2.2 Selleck Chemicals Gandotinib Product Portfolio
7.2.3 Selleck Chemicals Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Selleck Chemicals Main Business and Markets Served
7.2.5 Selleck Chemicals Recent Developments/Updates
7.3 BOC Sciences
7.3.1 BOC Sciences Gandotinib Corporation Information
7.3.2 BOC Sciences Gandotinib Product Portfolio
7.3.3 BOC Sciences Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.3.4 BOC Sciences Main Business and Markets Served
7.3.5 BOC Sciences Recent Developments/Updates
7.4 TargetMol
7.4.1 TargetMol Gandotinib Corporation Information
7.4.2 TargetMol Gandotinib Product Portfolio
7.4.3 TargetMol Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.4.4 TargetMol Main Business and Markets Served
7.4.5 TargetMol Recent Developments/Updates
7.5 MyBiosource
7.5.1 MyBiosource Gandotinib Corporation Information
7.5.2 MyBiosource Gandotinib Product Portfolio
7.5.3 MyBiosource Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.5.4 MyBiosource Main Business and Markets Served
7.5.5 MyBiosource Recent Developments/Updates
7.6 Adooq Bioscience
7.6.1 Adooq Bioscience Gandotinib Corporation Information
7.6.2 Adooq Bioscience Gandotinib Product Portfolio
7.6.3 Adooq Bioscience Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Adooq Bioscience Main Business and Markets Served
7.6.5 Adooq Bioscience Recent Developments/Updates
7.7 Toronto Research Chemicals
7.7.1 Toronto Research Chemicals Gandotinib Corporation Information
7.7.2 Toronto Research Chemicals Gandotinib Product Portfolio
7.7.3 Toronto Research Chemicals Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Toronto Research Chemicals Main Business and Markets Served
7.7.5 Toronto Research Chemicals Recent Developments/Updates
7.8 AbMole
7.8.1 AbMole Gandotinib Corporation Information
7.8.2 AbMole Gandotinib Product Portfolio
7.8.3 AbMole Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.8.4 AbMole Main Business and Markets Served
7.7.5 AbMole Recent Developments/Updates
7.9 Taiclone
7.9.1 Taiclone Gandotinib Corporation Information
7.9.2 Taiclone Gandotinib Product Portfolio
7.9.3 Taiclone Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Taiclone Main Business and Markets Served
7.9.5 Taiclone Recent Developments/Updates
7.10 Axon Medchem
7.10.1 Axon Medchem Gandotinib Corporation Information
7.10.2 Axon Medchem Gandotinib Product Portfolio
7.10.3 Axon Medchem Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Axon Medchem Main Business and Markets Served
7.10.5 Axon Medchem Recent Developments/Updates
7.11 CSNpharm
7.11.1 CSNpharm Gandotinib Corporation Information
7.11.2 CSNpharm Gandotinib Product Portfolio
7.11.3 CSNpharm Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.11.4 CSNpharm Main Business and Markets Served
7.11.5 CSNpharm Recent Developments/Updates
7.12 AA BLOCKS
7.12.1 AA BLOCKS Gandotinib Corporation Information
7.12.2 AA BLOCKS Gandotinib Product Portfolio
7.12.3 AA BLOCKS Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.12.4 AA BLOCKS Main Business and Markets Served
7.12.5 AA BLOCKS Recent Developments/Updates
7.13 MedKoo
7.13.1 MedKoo Gandotinib Corporation Information
7.13.2 MedKoo Gandotinib Product Portfolio
7.13.3 MedKoo Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.13.4 MedKoo Main Business and Markets Served
7.13.5 MedKoo Recent Developments/Updates
7.14 Wuhan Sun-Shine Bio-Technology
7.14.1 Wuhan Sun-Shine Bio-Technology Gandotinib Corporation Information
7.14.2 Wuhan Sun-Shine Bio-Technology Gandotinib Product Portfolio
7.14.3 Wuhan Sun-Shine Bio-Technology Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Wuhan Sun-Shine Bio-Technology Main Business and Markets Served
7.14.5 Wuhan Sun-Shine Bio-Technology Recent Developments/Updates
7.15 Biosynth Carbosynth
7.15.1 Biosynth Carbosynth Gandotinib Corporation Information
7.15.2 Biosynth Carbosynth Gandotinib Product Portfolio
7.15.3 Biosynth Carbosynth Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Biosynth Carbosynth Main Business and Markets Served
7.15.5 Biosynth Carbosynth Recent Developments/Updates
7.16 Biorbyt
7.16.1 Biorbyt Gandotinib Corporation Information
7.16.2 Biorbyt Gandotinib Product Portfolio
7.16.3 Biorbyt Gandotinib Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Biorbyt Main Business and Markets Served
7.16.5 Biorbyt Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Gandotinib Industry Chain Analysis
8.2 Gandotinib Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Gandotinib Production Mode & Process
8.4 Gandotinib Sales and Marketing
8.4.1 Gandotinib Sales Channels
8.4.2 Gandotinib Distributors
8.5 Gandotinib Customers
9 Gandotinib Market Dynamics
9.1 Gandotinib Industry Trends
9.2 Gandotinib Market Drivers
9.3 Gandotinib Market Challenges
9.4 Gandotinib Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gandotinib Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Gandotinib Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Gandotinib Production Capacity (Kg) by Manufacturers in 2023
Table 4. Global Gandotinib Production by Manufacturers (2019-2024) & (Kg)
Table 5. Global Gandotinib Production Market Share by Manufacturers (2019-2024)
Table 6. Global Gandotinib Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Gandotinib Production Value Share by Manufacturers (2019-2024)
Table 8. Global Gandotinib Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gandotinib as of 2023)
Table 10. Global Market Gandotinib Average Price by Manufacturers (K USD/Kg) & (2019-2024)
Table 11. Manufacturers Gandotinib Production Sites and Area Served
Table 12. Manufacturers Gandotinib Product Types
Table 13. Global Gandotinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Gandotinib Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Gandotinib Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Gandotinib Production Value Market Share by Region (2019-2024)
Table 18. Global Gandotinib Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Gandotinib Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Gandotinib Production Comparison by Region: 2019 VS 2023 VS 2030 (Kg)
Table 21. Global Gandotinib Production (Kg) by Region (2019-2024)
Table 22. Global Gandotinib Production Market Share by Region (2019-2024)
Table 23. Global Gandotinib Production (Kg) Forecast by Region (2025-2030)
Table 24. Global Gandotinib Production Market Share Forecast by Region (2025-2030)
Table 25. Global Gandotinib Market Average Price (K USD/Kg) by Region (2019-2024)
Table 26. Global Gandotinib Market Average Price (K USD/Kg) by Region (2025-2030)
Table 27. Global Gandotinib Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kg)
Table 28. Global Gandotinib Consumption by Region (2019-2024) & (Kg)
Table 29. Global Gandotinib Consumption Market Share by Region (2019-2024)
Table 30. Global Gandotinib Forecasted Consumption by Region (2025-2030) & (Kg)
Table 31. Global Gandotinib Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Gandotinib Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 33. North America Gandotinib Consumption by Country (2019-2024) & (Kg)
Table 34. North America Gandotinib Consumption by Country (2025-2030) & (Kg)
Table 35. Europe Gandotinib Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 36. Europe Gandotinib Consumption by Country (2019-2024) & (Kg)
Table 37. Europe Gandotinib Consumption by Country (2025-2030) & (Kg)
Table 38. Asia Pacific Gandotinib Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kg)
Table 39. Asia Pacific Gandotinib Consumption by Region (2019-2024) & (Kg)
Table 40. Asia Pacific Gandotinib Consumption by Region (2025-2030) & (Kg)
Table 41. Latin America, Middle East & Africa Gandotinib Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 42. Latin America, Middle East & Africa Gandotinib Consumption by Country (2019-2024) & (Kg)
Table 43. Latin America, Middle East & Africa Gandotinib Consumption by Country (2025-2030) & (Kg)
Table 44. Global Gandotinib Production (Kg) by Type (2019-2024)
Table 45. Global Gandotinib Production (Kg) by Type (2025-2030)
Table 46. Global Gandotinib Production Market Share by Type (2019-2024)
Table 47. Global Gandotinib Production Market Share by Type (2025-2030)
Table 48. Global Gandotinib Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Gandotinib Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Gandotinib Production Value Share by Type (2019-2024)
Table 51. Global Gandotinib Production Value Share by Type (2025-2030)
Table 52. Global Gandotinib Price (K USD/Kg) by Type (2019-2024)
Table 53. Global Gandotinib Price (K USD/Kg) by Type (2025-2030)
Table 54. Global Gandotinib Production (Kg) by Application (2019-2024)
Table 55. Global Gandotinib Production (Kg) by Application (2025-2030)
Table 56. Global Gandotinib Production Market Share by Application (2019-2024)
Table 57. Global Gandotinib Production Market Share by Application (2025-2030)
Table 58. Global Gandotinib Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Gandotinib Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Gandotinib Production Value Share by Application (2019-2024)
Table 61. Global Gandotinib Production Value Share by Application (2025-2030)
Table 62. Global Gandotinib Price (K USD/Kg) by Application (2019-2024)
Table 63. Global Gandotinib Price (K USD/Kg) by Application (2025-2030)
Table 64. BioVision Gandotinib Corporation Information
Table 65. BioVision Specification and Application
Table 66. BioVision Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 67. BioVision Main Business and Markets Served
Table 68. BioVision Recent Developments/Updates
Table 69. Selleck Chemicals Gandotinib Corporation Information
Table 70. Selleck Chemicals Specification and Application
Table 71. Selleck Chemicals Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 72. Selleck Chemicals Main Business and Markets Served
Table 73. Selleck Chemicals Recent Developments/Updates
Table 74. BOC Sciences Gandotinib Corporation Information
Table 75. BOC Sciences Specification and Application
Table 76. BOC Sciences Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 77. BOC Sciences Main Business and Markets Served
Table 78. BOC Sciences Recent Developments/Updates
Table 79. TargetMol Gandotinib Corporation Information
Table 80. TargetMol Specification and Application
Table 81. TargetMol Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 82. TargetMol Main Business and Markets Served
Table 83. TargetMol Recent Developments/Updates
Table 84. MyBiosource Gandotinib Corporation Information
Table 85. MyBiosource Specification and Application
Table 86. MyBiosource Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 87. MyBiosource Main Business and Markets Served
Table 88. MyBiosource Recent Developments/Updates
Table 89. Adooq Bioscience Gandotinib Corporation Information
Table 90. Adooq Bioscience Specification and Application
Table 91. Adooq Bioscience Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 92. Adooq Bioscience Main Business and Markets Served
Table 93. Adooq Bioscience Recent Developments/Updates
Table 94. Toronto Research Chemicals Gandotinib Corporation Information
Table 95. Toronto Research Chemicals Specification and Application
Table 96. Toronto Research Chemicals Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 97. Toronto Research Chemicals Main Business and Markets Served
Table 98. Toronto Research Chemicals Recent Developments/Updates
Table 99. AbMole Gandotinib Corporation Information
Table 100. AbMole Specification and Application
Table 101. AbMole Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 102. AbMole Main Business and Markets Served
Table 103. AbMole Recent Developments/Updates
Table 104. Taiclone Gandotinib Corporation Information
Table 105. Taiclone Specification and Application
Table 106. Taiclone Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 107. Taiclone Main Business and Markets Served
Table 108. Taiclone Recent Developments/Updates
Table 109. Axon Medchem Gandotinib Corporation Information
Table 110. Axon Medchem Specification and Application
Table 111. Axon Medchem Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 112. Axon Medchem Main Business and Markets Served
Table 113. Axon Medchem Recent Developments/Updates
Table 114. CSNpharm Gandotinib Corporation Information
Table 115. CSNpharm Specification and Application
Table 116. CSNpharm Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 117. CSNpharm Main Business and Markets Served
Table 118. CSNpharm Recent Developments/Updates
Table 119. AA BLOCKS Gandotinib Corporation Information
Table 120. AA BLOCKS Specification and Application
Table 121. AA BLOCKS Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 122. AA BLOCKS Main Business and Markets Served
Table 123. AA BLOCKS Recent Developments/Updates
Table 124. MedKoo Gandotinib Corporation Information
Table 125. MedKoo Specification and Application
Table 126. MedKoo Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 127. MedKoo Main Business and Markets Served
Table 128. MedKoo Recent Developments/Updates
Table 129. Wuhan Sun-Shine Bio-Technology Gandotinib Corporation Information
Table 130. Wuhan Sun-Shine Bio-Technology Specification and Application
Table 131. Wuhan Sun-Shine Bio-Technology Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 132. Wuhan Sun-Shine Bio-Technology Main Business and Markets Served
Table 133. Wuhan Sun-Shine Bio-Technology Recent Developments/Updates
Table 134. Wuhan Sun-Shine Bio-Technology Gandotinib Corporation Information
Table 135. Biosynth Carbosynth Specification and Application
Table 136. Biosynth Carbosynth Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 137. Biosynth Carbosynth Main Business and Markets Served
Table 138. Biosynth Carbosynth Recent Developments/Updates
Table 139. Biorbyt Gandotinib Corporation Information
Table 140. Biorbyt Gandotinib Production (Kg), Value (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)
Table 141. Biorbyt Main Business and Markets Served
Table 142. Biorbyt Recent Developments/Updates
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Gandotinib Distributors List
Table 146. Gandotinib Customers List
Table 147. Gandotinib Market Trends
Table 148. Gandotinib Market Drivers
Table 149. Gandotinib Market Challenges
Table 150. Gandotinib Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gandotinib
Figure 2. Global Gandotinib Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Gandotinib Market Share by Type: 2023 VS 2030
Figure 4. Min Purity Less Than 98% Product Picture
Figure 5. Min Purity 98%-99% Product Picture
Figure 6. Min Purity More Than 99% Product Picture
Figure 7. Global Gandotinib Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 8. Global Gandotinib Market Share by Application: 2023 VS 2030
Figure 9. Research
Figure 10. Medical
Figure 11. Global Gandotinib Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Gandotinib Production Value (US$ Million) & (2019-2030)
Figure 13. Global Gandotinib Production Capacity (Kg) & (2019-2030)
Figure 14. Global Gandotinib Production (Kg) & (2019-2030)
Figure 15. Global Gandotinib Average Price (K USD/Kg) & (2019-2030)
Figure 16. Gandotinib Report Years Considered
Figure 17. Gandotinib Production Share by Manufacturers in 2023
Figure 18. Gandotinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. The Global 5 and 10 Largest Players: Market Share by Gandotinib Revenue in 2023
Figure 20. Global Gandotinib Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Gandotinib Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 22. Global Gandotinib Production Comparison by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 23. Global Gandotinib Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. North America Gandotinib Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. Europe Gandotinib Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. China Gandotinib Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Japan Gandotinib Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Taiwan,China Gandotinib Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Global Gandotinib Consumption by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 30. Global Gandotinib Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 32. North America Gandotinib Consumption Market Share by Country (2019-2030)
Figure 33. Canada Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 34. U.S. Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 35. Europe Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 36. Europe Gandotinib Consumption Market Share by Country (2019-2030)
Figure 37. Germany Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 38. France Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 39. U.K. Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 40. Italy Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 41. Russia Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 42. Asia Pacific Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 43. Asia Pacific Gandotinib Consumption Market Share by Regions (2019-2030)
Figure 44. China Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 45. Japan Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 46. South Korea Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 47. China Taiwan Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 48. Southeast Asia Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 49. India Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 50. Latin America, Middle East & Africa Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 51. Latin America, Middle East & Africa Gandotinib Consumption Market Share by Country (2019-2030)
Figure 52. Mexico Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 53. Brazil Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 54. Turkey Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 55. GCC Countries Gandotinib Consumption and Growth Rate (2019-2024) & (Kg)
Figure 56. Global Production Market Share of Gandotinib by Type (2019-2030)
Figure 57. Global Production Value Market Share of Gandotinib by Type (2019-2030)
Figure 58. Global Gandotinib Price (K USD/Kg) by Type (2019-2030)
Figure 59. Global Production Market Share of Gandotinib by Application (2019-2030)
Figure 60. Global Production Value Market Share of Gandotinib by Application (2019-2030)
Figure 61. Global Gandotinib Price (K USD/Kg) by Application (2019-2030)
Figure 62. Gandotinib Value Chain
Figure 63. Gandotinib Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
